TCSAM
AVIR icon

Tyrus Capital S.A.M.’s Atea Pharmaceuticals AVIR Stock Holding History

Tyrus Capital S.A.M.’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		$3.78M Hold
1,260,000
– – 35.9% 1
2023
Q2 		$4.71M Hold
1,260,000
– – 33.11% 1
2023
Q1 		$4.22M Hold
1,260,000
– – 24.86% 1
2022
Q4 		$6.06M Buy
+1,260,000
New +$6.06M 13.2% 2